Full Text View
Tabular View
No Study Results Posted
Related Studies
Spinal Cord Stimulation Research Study (ADR-SCS)
This study is currently recruiting participants.
Verified by MedtronicNeuro, December 2008
First Received: October 7, 2008   Last Updated: December 29, 2008   History of Changes
Sponsored by: MedtronicNeuro
Information provided by: MedtronicNeuro
ClinicalTrials.gov Identifier: NCT00768872
  Purpose

The purpose of this study is to characterize a patient's activity levels before and after spinal cord stimulation therapy.


Condition
Chronic Low Back and Leg Pain

U.S. FDA Resources
Study Type: Observational
Study Design: Case-Only, Prospective
Official Title: Neuro Ambulatory Data Recorder (ADR) Spinal Cord Stimulation (SCS) Study

Further study details as provided by MedtronicNeuro:

Estimated Enrollment: 33
Study Start Date: October 2008
Estimated Study Completion Date: October 2010
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Candidates for Spinal Cord Stimulation

Criteria

Inclusion Criteria:

  • 18 years of age or older
  • Candidate for SCS device trial
  • Subject is ambulatory
  • Diagnosed with low back pain or low back pain plus leg pain for at least 6 months
  • Undergoing treatment for low back pain or low back pain plus leg pain
  • Does not have or has not had a previous SCS implant
  • Willing and able to complete protocol requirements
  • Willing and able to sign the study-specific Informed Consent form
  • Male or non-pregnant female

Exclusion Criteria:

  • Have plans to enroll in another clinical study during their participation in this study, or are currently enrolled in a clinical study that could interfere in participation in the trial or affect the scientific soundness of this study
  • Cancer or any other malignant disease
  • Present or past diagnosis of schizophrenia or of delusional, psychotic, or dissociative disorder
  • A pain-related surgery in the previous 12 weeks of enrollment, the intent to undergo surgery during the period of the study
  • Non-English speaking or an inability to complete questionnaires accurately
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00768872

Contacts
Contact: Christa Nichols 952-974-4370 cnichols@painphysicians.com
Contact: Caroline Holcomb 617-732-9462 cholcomb@partners.org

Locations
United States, Massachusetts
Brigham and Women's Hospital Recruiting
Chestnut Hill, Massachusetts, United States, 02467
Contact: Caroline Holcomb     617-732-9462     cholcomb@partners.org    
United States, Minnesota
Medical Advanced Pain Specialists (MAPS) Recruiting
Edina, Minnesota, United States, 55435
Contact: Christa Nichols     952-974-4370 ext 234        
Sponsors and Collaborators
MedtronicNeuro
Investigators
Principal Investigator: David M Schultz, MD Medical Advanced Pain Specialists (MAPS)
Principal Investigator: Robert Jamison, Ph.D Brigham and Women's Hospital
  More Information

No publications provided

Responsible Party: Medtronic, Inc. ( Medtronic Neuromodulation )
Study ID Numbers: 1644
Study First Received: October 7, 2008
Last Updated: December 29, 2008
ClinicalTrials.gov Identifier: NCT00768872     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by MedtronicNeuro:
activity, spinal cord stimulation, pain

Study placed in the following topic categories:
Pain

ClinicalTrials.gov processed this record on May 07, 2009